Introduction {#s1}
============

Generally, liver regulates lipid metabolism by three major processes: (1) uptake free fatty acids from circulation, and *de novo* fatty acid synthesis (FAS); (2) lipid storage, including converting fatty acids into triglyceride (TG) and other lipid droplets, which are subsequently exported to adipose tissue or stored in liver; and (3) lipid consumption, including lipolysis, β-oxidation, and the generation of lipoproteins ([@B105]; [@B87]; [@B101]; [@B84]). These processes are presented in [**Figure 1**](#f1){ref-type="fig"}. Correct control of lipid level is critical for cellular and organismal homeostasis, while interferences with the lipogenic pathways are accompanied with a variety of metabolic syndromes. The disorders of lipid metabolism, such as decreased β‐oxidation, enhanced lipolysis, and secretion of very low-density lipoprotein (VLDL), as well as altered pathways involved in the FAS, drive the accumulation of lipid droplets into the hepatocytes, eventually leading to the development of hepatic steatosis, which is a common pathological feature in various liver diseases ([@B105]; [@B88]; [@B120]; [@B97]).

![Major processes involved in hepatic lipid metabolism.](fphar-11-00351-g001){#f1}

The most prevalent liver diseases resulting from lipid metabolism disorder are alcoholic and non-alcoholic fatty liver diseases. Except difference in alcohol consumption, alcoholic and non-alcoholic fatty liver diseases show similar pathological process, which is characterized by long-term excessive fat accumulation in the liver ([@B143]). They represent a wide range of liver injury, from simple fatty liver through steatosis with necrosis and inflammation to fibrosis and cirrhosis ([@B79]; [@B33]). In particular, non-alcoholic fatty liver diseases (NAFLD), as the metabolic diseases induced by obesity and type 2 diabetes mellitus, are the second leading causes of death globally, becoming a heavy economic burden in many countries due to the high prevalence ([@B2]; [@B3]). Since inordinate lipid metabolism is intensively involved in fatty liver diseases progression, reducing lipid accumulation is a major target of development of pharmaceutical agents for various liver diseases ([@B42]). Simvastatin has been used as lipid-lowing drug in patients with hyperlipidemia ([@B6]). However, it shows side effects, such as constipation headaches, nausea, myopathy, elevated blood sugar, and even liver damage. As a matter of fact, there is currently no satisfying therapeutic drug for fatty liver diseases ([@B43]; [@B86]).

Over the past decades, due to the positive efficacy and minimal side effects, herbal medicines, and natural products have obtained increasing attention as alternative therapeutic agents for liver disorders and dyslipidemia ([@B132]; [@B141]; [@B73]). Growing evidence from preclinical studies suggests that many herbs and isolated compounds could inhibit the progression of hepatic steatosis ([@B24]; [@B72]). A variety of mechanisms have been demonstrated to be implicated in preventing hepatic steatosis, including reducing lipogenesis, enhancing β-oxidation, increasing insulin sensitivity, suppressing oxidative stress, and inhibiting activation of inflammatory pathways ([@B24]; [@B141]). In recent studies, sterol regulatory elementbinding protein 1c (SREBP-1c), peroxisome proliferator activated receptor α (PPARα), AMP-activated protein kinase (AMPK) and sirtuin 1 (SIRT1) signaling pathways have been highlighted as crucial molecular targets of action mechanisms by which herbal medicines regulate hepatic lipid metabolism ([@B72]). In this review, herbal medicines involved in regulating hepatic lipolytic and lipogenic pathways, such as mitochondrial and peroxisomal β-oxidation, the secretion of very low-density lipoprotein (VLDL), the non-esterified fatty acid (NEFA) uptake, and some vital hepatic lipogenic enzymes are summarized. Current clinical evidences and meta-analysis in the positive impacts of herbal medicines on the hepatic lipid metabolism pathways have also been reviewed. Furthermore, several herbal formulae, herbs or herbal derivatives, such as Erchen Dection, Danshen, resveratrol, and berberine which have been extensively studied for their promising potential in mediating lipid metabolism, are particularly highlighted in this review. This review aims to update and summarize current evidence from laboratory and clinic studies to provide alternative and complementary medical therapies with the regulatory property of hepatic lipid metabolism to current pharmaceuticals for the treatment of liver diseases.

Herbal Medicines and Natural Products Regulate on the Hepatic Lipid Metabolism Pathways {#s2}
=======================================================================================

Increasing evidence indicated that many herbs, natural products, and their derived compounds could inhibit the progression of hepatic steatosis. A variety of mechanisms have been demonstrated to be implicated in preventing hepatic steatosis and modulating lipid metabolism by herbs, including anti-oxidative stress, anti-inflammation, reducing hepatocyte fatty acid uptake and trafficking, reducing hepatic *de novo* lipogenesis, increasing lipolysis, induction of lipophagy, enhancing fatty acid β-oxidation. In particular, SREBP-1c, PPARα, AMPK, and SIRT1 signaling pathways have been highlighted as crucial molecular targets of action mechanisms by which herbal medicines regulate hepatic lipid metabolism. In [**Table 1**](#T1){ref-type="table"}, we reviewed the effects and mechanisms of herbs and some natural products on fatty liver diseases from recent studies. In the following section, we will discuss herbs that attenuate hepatic steatosis *via* reducing hepatocyte fatty acid uptake and trafficking, reducing hepatic *de novo* lipogenesis, increasing lipolysis, induction of lipophagy, and enhancing fatty acid β-oxidation in detail.

###### 

The effects and mechanisms of herbs and some natural products on fatty liver diseases.

  Herbs or Natural products                                                                                                                                                                                                                                                                                                                                                                                              Model                                                                                Effects                                                                                                                                                                          Mechanisms                                                                                                                                                                                                                                                                                                                                                   References
  ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ----------------------------
  *Rosmarinus officinalis* Linn.                                                                                                                                                                                                                                                                                                                                                                                         Orotic acid induced NAFLD model in rats                                              Reduced the levels of hepatic TG, TC, FFA and improved cell hypertrophy, vacuolation, and cell necrosis in the liver                                                             ↑Phosphorylation of AMPK and ↓SREBP-1c cracking into the nucleus, following ↓FAS                                                                                                                                                                                                                                                                             ([@B129])
  Chinese Herbal Formula (CHF03, composition confidentiality)                                                                                                                                                                                                                                                                                                                                                            HFD induced NAFLD model in mice; AML12 cells treated with palmitic acid *in vitro*   Reduced hepatic steatosis                                                                                                                                                        ↓lipogenesis *via* down-regulating the expression of SREBF1, Fasn, and Acaca, ↓ lipid accumulation                                                                                                                                                                                                                                                           ([@B21])
  Dachaihu Decoction (Bupleuri Radix, Scutellaria baicalensis Georgi, Pinellia ternate, Paeonia lactiflora, Citrus trifoliata, Rheum rhabarbarum, Zingiber officinale, Ziziphus jujuba Mill)                                                                                                                                                                                                                             High-fat high-fructose diet induced NAFLD model in rats                              Reduced the levels of elevated liver coefficient, serum TG, TC, LDL, AST, and ALT, blood glucose, plasma endotoxin, reduced TG, TNF-α, TGF-β, NF-κB, and TLR4 in liver tissues   ↓oxidative stress and inflammation                                                                                                                                                                                                                                                                                                                           ([@B137])
  Leaves of *Aloysia citrodora* Paláu (syn. Lippia triphylla)                                                                                                                                                                                                                                                                                                                                                            KK‐Ay mice                                                                           Improved hepatic lipid metabolism                                                                                                                                                via activating AMPK                                                                                                                                                                                                                                                                                                                                          ([@B152])
  Polygonatum kingianum                                                                                                                                                                                                                                                                                                                                                                                                  HFD induced NAFLD model in rats                                                      ↓ALT, AST, TC, LDL in serum, and hepatic TC and TG                                                                                                                               ↑mRNA expression of carnitine palmitoyl transferase-1 and ↓uncoupling protein-2 respectively, ↓caspase 9, caspase 3 and Bax expression in hepatocytes, ↑expression of Bcl-2 in hepatocytes and cytchrome c in mitochondria                                                                                                                                   ([@B139])
  Bangpungtongseong-san (Bofutsushosan)                                                                                                                                                                                                                                                                                                                                                                                  HFD induced NAFLD model in C57BL/6J mice                                             Ameliorated dyslipidemia and hepatic steatosis, reduced body weight gain                                                                                                         Altered transcriptional changes in the liver, ↓mitochondrial oxidative phosphorylation-related genes in the liver, ↓hepatic fibrosis-related transcriptome.                                                                                                                                                                                                  ([@B20])
  Thymbra spicata L. extracts                                                                                                                                                                                                                                                                                                                                                                                            endothelial cells *in vitro*                                                         Ameliorated lipid accumulation, oxidative stress and inflammation, reduced hepatic steatosis                                                                                     Preventing endothelium dysfunction                                                                                                                                                                                                                                                                                                                           ([@B49])
  Swertiamarin                                                                                                                                                                                                                                                                                                                                                                                                           fructose-fed mice                                                                    Lowed levels of serum glucose, TG, uric acid, ALT, AST, alleviation of hepatic ballooning degeneration and steatosis                                                             ↓SREBP-1, FAS and acetyl-CoA carboxylase 1 (ACC1) in liver                                                                                                                                                                                                                                                                                                   ([@B140])
  Si He Decoction (Zingiber officinale., Cyperus rotundus L., Lilium, Lindera aggregate, Salvia miltiorrhiza, Santalum album, Amomum villosum, *Typha angustifolia* L., Trogopterus xanthipes Milne)                                                                                                                                                                                                                     HFD induced NAFLD model in rats                                                      Improved liver pathological conditions                                                                                                                                           ↓expression level of TNF-alpha and IL-6, ↑visfatin, adiponectin, leptin and resistin, targeting adipokines                                                                                                                                                                                                                                                   ([@B119])
  Modified Longdan Xiegan Tang (composed of *Scutellaria baicalnsis* Geprgi, *Gardenia jasminoides, Adenophora capillaris, Akebia quinate, Plantago asiatica, Angelica sinensis, Rehmannia glutinosa, Alisma plantago-aquatica, Bupleurum gibraltaicum*, and *Glycyrrhiza uralensis*)                                                                                                                                    Olanzapine-induced fatty liver in rats                                               ↓TG, cell vacuolar degeneration and Oil Red O-stained area                                                                                                                       Regulating hepatic *de novo* lipogenesis and fatty acid β-oxidation-associated Gene expression mediated by SREBP-1c, PPAR-α and AMPK-α                                                                                                                                                                                                                       ([@B106])
  LongShengZhi Capsule                                                                                                                                                                                                                                                                                                                                                                                                   apoE-Deficient Mice                                                                  Reduced atherosclerosis                                                                                                                                                          ↓lipogenic and cholesterol synthetic genes while activating expression of triglyceride catabolism genes                                                                                                                                                                                                                                                      ([@B82])
  Thymoquinone                                                                                                                                                                                                                                                                                                                                                                                                           Hypothyroidism with NAFLD rats                                                       Reduced steatosis and lobular inflammation                                                                                                                                       ↑antioxidant CAT gene                                                                                                                                                                                                                                                                                                                                        ([@B7])
  Monomer Hairy Calycosin                                                                                                                                                                                                                                                                                                                                                                                                NAFLD rats                                                                           Control the lipid peroxidation, and reduce the levels of serum TNF-alpha, IL-6, MDA and FFA, improve the steatosis and inflammation of liver tissue                              ↓CYP2E1, ↓apoptosis of hepatocytes.                                                                                                                                                                                                                                                                                                                          ([@B76])
  Hongqi Jiangzhi Formula (Astragali Radix, Red yeast rice, Nelumbinis Folium, Curcumae Longae Rhizoma, Lych Fructus, Magnoliae Officinals Cortex, Artemisiae Scopariae Herba)                                                                                                                                                                                                                                           HFD induced NAFLD model in rats                                                      Reduced lipid accumulation                                                                                                                                                       ↓the expression of NF-kappa B through TLR4 downstream signalling pathways                                                                                                                                                                                                                                                                                    ([@B67])
  Jiang Zhi Granule (Herba Gynostemmatis, Folium Nelumbinis, Radix Salviae, Rhizoma Polygoni Cuspidati, and Herba Artemisiae Scopariae)                                                                                                                                                                                                                                                                                  NAFLD in animal and PA-treated hepatocytes *in vitro*                                Showed anti-steatotic effects                                                                                                                                                    droplet degradation *via* autophagy though the mTOR signalling                                                                                                                                                                                                                                                                                               ([@B153])
  Curcumin                                                                                                                                                                                                                                                                                                                                                                                                               Steatotic hepatocyte model *in vitro* and NAFLD rat models                           Improved lipid accumulation                                                                                                                                                      Reversed the DNA methylation at the PPAR-alpha gene                                                                                                                                                                                                                                                                                                          ([@B65])
  Samjunghwan Herbal Formula (Mori Fructus, *Lycium chinensis* Miller, Atractylodis Rhizoma)                                                                                                                                                                                                                                                                                                                             HepG2 Cells and OLETF Rats                                                           ↓Body weights, and visceral adipose tissue (VAT) weights, AST and ALT levels,                                                                                                    ↑HMGCOR, SREBP, and ACC, and ↓AMPK and LDLR gene expressions levels.                                                                                                                                                                                                                                                                                         ([@B4])
  Oxyresveratrol                                                                                                                                                                                                                                                                                                                                                                                                         NAFLD in mice                                                                        Ameliorated NAFLD                                                                                                                                                                ↓LXR alpha agonists-mediated SREBP-1c induction and expression of the lipogenic genes, ↑mRNA of fatty acid beta-oxidation-related genes in hepatocytes; induced AMPK activation, helped inhibit SREBP-1c using compound C.                                                                                                                                   ([@B58])
  Sedum sarmentosum Bunge extract                                                                                                                                                                                                                                                                                                                                                                                        Tilapia fatty liver model                                                            Restored the changes to feed coefficient, immune capacity, and pathological characters                                                                                           Altered expression of genes in the lipid metabolic process, metabolic process, and oxidation-reduction process. Our results suggest that disorders of the PPAR and p53 signaling pathways                                                                                                                                                                    ([@B38])
  Berberine and curcumin                                                                                                                                                                                                                                                                                                                                                                                                 HFD induced NAFLD model in rats                                                      ↓LDL-c, ALT, AST, ALP, MDA, LSP                                                                                                                                                  ↓SREBP-1c, pERK, TNF-alpha, and pJNK                                                                                                                                                                                                                                                                                                                         ([@B27])
  Gegen Qinlian decoction (Pueraria lacei Craib, Scutellaria baicalensis Georgi, Coptis chinensis Franch., and Glycyrrhiza uralensis Fisch.) and resveratrol                                                                                                                                                                                                                                                             Rat model of HFD-induced NAFLD                                                       Restored lipid metabolism and inflammatory and histological abnormalities                                                                                                        Triggering the Sirt1 pathway                                                                                                                                                                                                                                                                                                                                 ([@B31])
  Gegenqinlian Decoction                                                                                                                                                                                                                                                                                                                                                                                                 Rat model of HFD-induced NAFLD and HepG2                                             Suppress inflammation and regulate lipid                                                                                                                                         Improving PPAR-γ                                                                                                                                                                                                                                                                                                                                             ([@B126])
  Lingguizhugan Decoction (Poria, Ramulus Cinnamomi, Rhizoma Atractylodis Macrocephalae, and Radix Glycyrrhizae)                                                                                                                                                                                                                                                                                                         Rat model of HFD-induced NAFLD                                                       Attenuated phenotypic characteristics of NAFLD                                                                                                                                   By affecting insulin resistance and lipid metabolism related pathways (e.g., PI3K-Akt, AMPK); activating cholesterol secretio; increasing serum thyroid hormone levels, improving beta-oxidation (via modulation of TR beta 1 and CPT1A expression), metabolism and transport (through modulation of SREBP-1c, ACSL and ApoB100 expression) of fatty acid.   ([@B74]; [@B136]; [@B156])
  Chinese herb extract, QSHX (*Bupleurum falcatum*, *Salvia miltiorrhiza*, rhubarb, lotus leaf, capillary Artemisia, rhizome polygoni cuspidate and gyn*ostemma pentaphyllum*)                                                                                                                                                                                                                                           High-fat and high-sugar diet-induced NAFLD in rat                                    ↓Body weight, liver index, and serum levels of AST, ALT and TG; and increased the serum level of adiponectin                                                                     Promoting the expression of HMW APN and DsbA-L, which may have been induced by inhibiting the activation and expression of FOXO1 in adipocytes                                                                                                                                                                                                               ([@B74])
  Qushi Huayu Decoction (*Herba Artemisiae* capillaris, *Polygonum cuspidatum*, *Hypericum japonicum* Thunb, Gardenia, and *Rhizoma Curcumae* Longae)                                                                                                                                                                                                                                                                    NAFLD rats                                                                           Attenuated phenotypic characteristics of NAFLD                                                                                                                                   ↑Hepatic anti-oxidative mechanism, ↓hepatic lipid synthesis, and promoted the regulatory T cell inducing microbiota in the gut.                                                                                                                                                                                                                              ([@B26])
  Rhododendron oldhamii Maxim. leaf extract                                                                                                                                                                                                                                                                                                                                                                              HepG2 cells and HFD-fed mice                                                         Improves fatty liver syndrome                                                                                                                                                    Increasing lipid oxidation and decreasing the lipogenesis pathway                                                                                                                                                                                                                                                                                            ([@B75])
  Herbal Formula HT048 (*Crataegus pinnatifida* leaf and *Citrus unshiu* peel extracts.)                                                                                                                                                                                                                                                                                                                                 HFD-fed rats                                                                         Attenuates Diet-Induced Obesity                                                                                                                                                  ↓Genes involved in lipogenesis, gluconeogenesis, and adipogenesis, ↑β--oxidation genes                                                                                                                                                                                                                                                                       ([@B57])
  Angelica dahurica (Hoffm.) Benth. & Hook.f. ex Franch. & Sav.                                                                                                                                                                                                                                                                                                                                                          HFD-induced hyperlipidemic mice                                                      ↓TC and TG in the livers                                                                                                                                                         ↓CAT and sterol carrier protein2 (SCP2), ↑ the expression of lipid metabolism related genes-lipase member C (LIPC) and PPAR-γ                                                                                                                                                                                                                                ([@B80])
  Daisaikoto (Bupleuri Radix, Scutellaria baicalensis Georgi, Pinellia ternate, Paeonia lactiflora, Citrus trifoliata, Rheum rhabarbarum, Zingiber officinale, Ziziphus jujuba Mill)                                                                                                                                                                                                                                     Diabetic fatty liver rats induced by a high-fat diet and streptozotocin (STZ)        Reversing dyslipidemia and insulin resistance                                                                                                                                    Regulating expressions of SIRT1 and NF-κB                                                                                                                                                                                                                                                                                                                    ([@B102])
  Herb Formula KIOM2012H (*Arctium lappa* Linne, *Glycyrrhiza uralensis* Fischer, *Magnolia officinalis* Rehder & Wilson, Zingiber officinale Roscoe)                                                                                                                                                                                                                                                                    HFD-fed mice                                                                         Inhibited lipid accumulation                                                                                                                                                     Gene expressions involved in lipogenesis and related regulators                                                                                                                                                                                                                                                                                              ([@B93])
  Hawthorn (Crataegus) leaf flavonoids                                                                                                                                                                                                                                                                                                                                                                                   HFD-fed rats                                                                         Alleviated NAFLD                                                                                                                                                                 Enhancing the adiponectin/AMPK pathway                                                                                                                                                                                                                                                                                                                       ([@B62])
  Herbal SGR Formula (Semen Hoveniae extract, *Ginkgo biloba* extract, and *Rosa roxburghii* Tratt extract)                                                                                                                                                                                                                                                                                                              Acute ethanol-induced liver steatosis in mice                                        Inhibited acute ethanol-induced liver steatosis, ↓serum and hepatic TG level, and improved classic histopathological changes                                                     ↓Protein expression of hepatic SREBP-1c and TNF-α and increased adiponectin, PPAR-α, and AMPK phosphorylation in the liver                                                                                                                                                                                                                                   ([@B103])
  Nitraria retusa (Forssk.) Asch. ethanolic extract                                                                                                                                                                                                                                                                                                                                                                      db/db mice model                                                                     ↓Increases in body and fat mass weight, ↓TG and LDL-c levels                                                                                                                     ↑Gene expression related to lipid homeostasis in liver, modulating the lipolysis-lipogenesis balance                                                                                                                                                                                                                                                         ([@B146])
  14-Deoxyandrographolide                                                                                                                                                                                                                                                                                                                                                                                                Ethanol-induced hepatosteatosis in rats                                              Alleviate hepatosteatosis                                                                                                                                                        ↑AMPK, ↓SREBP-1c, ACC, and FAS, ↑sirtuin I and depletion of malonyl-CoA, ↑fatty acid oxidation                                                                                                                                                                                                                                                               ([@B83])
  Total Alkaloids in Rubus aleaefolius Poir                                                                                                                                                                                                                                                                                                                                                                              Modified HFD-fed rats                                                                ↓TG, TC, and LDL-C levels and ↑HDL-C level                                                                                                                                       ↓Expression of FAS, ACC, ↑carnitine palmitoyltransferase (CPT)                                                                                                                                                                                                                                                                                               ([@B61])
  Lycium barbarum L. polysaccharide                                                                                                                                                                                                                                                                                                                                                                                      HFD-fed mice                                                                         Improved body compositions and lipid metabolic profiles, ↓hepatic intracellular TG                                                                                               ↓SREBP-1c, ↑AMPK activation                                                                                                                                                                                                                                                                                                                                  ([@B60])
  Salacia oblonga Wall. ex Wight & Arn. root                                                                                                                                                                                                                                                                                                                                                                             fructose-induced fatty liver in rats                                                 Diminished fructose-induced fatty liver                                                                                                                                          ↓SREBP-1/1c mRNA and nuclear protein                                                                                                                                                                                                                                                                                                                         ([@B71])
  Chunggan extract (*Artemisia capillaries* Thunberg, *Trionyx sinensis* Wiegmann, *Raphanus sativus* Linne, *tractylodes macrocephala* Koidz, *Poria cocos* Wolf, *Alisma orientalis (Sam.)* Juzepczuk, *Atractylodes chinensis* Koidzumi, *Salvia miltiorrhiza* Bunge, *Polyporus umbellatus* Fries, *Poncirus trifoliate* Rafin, *Amomum villosum* Lour, *Glycyrrhiza uralensis* Fisch., *Aucklandia lappa* Decne.)   methionine- and choline-deficient (MCD) diet                                         ↓TG, AST, ALT, ALP, and total bilirubin                                                                                                                                          Anti-oxidative stress                                                                                                                                                                                                                                                                                                                                        ([@B92])
  Celastrus orbiculatus Thunb.                                                                                                                                                                                                                                                                                                                                                                                           HFD-induced NAFLD in guinea pigs                                                     ↓TC, free cholesterol (FC), cholesterol ester (CE) and TG in liver                                                                                                               ↑mRNA abundance of cholesterol 7 alpha-hydroxylase A1 (CYP7A1) and 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGCR).                                                                                                                                                                                                                                        ([@B147])
  Oxymatrine                                                                                                                                                                                                                                                                                                                                                                                                             NAFLD rats fed with high fructose diet                                               ↓Body weight gain, liver weight, liver index, dyslipidemia, and TG, ↓liver lipid accumulation.                                                                                   ↓ SREBF1 and ↑PPAR-α                                                                                                                                                                                                                                                                                                                                         ([@B115])
  Rhein                                                                                                                                                                                                                                                                                                                                                                                                                  HFD-induced obese mice                                                               ↓Body weight, particularly body fat content, improved insulin resistance, and ↓circulating cholesterol levels, ↓TG, reversed hepatic steatosis, and normalized ALT               Mediated negative energy balance, metabolic regulatory pathways, and immunomodulatory activities involved in hepatic steatosis                                                                                                                                                                                                                               ([@B112])
  Osthol                                                                                                                                                                                                                                                                                                                                                                                                                 Alcohol-induced fatty liver in mice                                                  Inhibit alcohol-induced fatty liver                                                                                                                                              Anti-oxidation and suppression of TNF-α production                                                                                                                                                                                                                                                                                                           ([@B118])

↑ means increase and up-regulate and ↓ means decrease and down-regulate.

Reducing Hepatocyte Fatty Acid Uptake and Trafficking {#s2_1}
-----------------------------------------------------

Nonesterified fatty acids (NEFAs) and glycerol are generated and released from adipose tissue *via* lipolysis ([@B48]). Then NEFAs enter into hepatocytes principally through CD36, and fatty acid transports (FATPs)([@B48]). Several mediators have been demonstrated to play a role in regulating CD36 and FATPs, such as pregnane X receptor (PXR), which impact the hepatocyte fatty acid uptake. Increasing evidence has shown that a variety of herbs and natural compounds attenuate hepatic steatosis *via* modulating genes for fatty acid uptake.

Scutellarin, one of the Traditional Chinese Medicines (TCM) used for liver diseases and diabetes, was found to reduce insulin-dependent lipid accumulation and the mRNA expression of CD36 in HepG2 cells-treated with palmitic acid ([@B81]). Several other TCM and isolated compounds, babaodan, licorice extract, polyphenol-enriched fraction from Herba Erigerontis, and magnesium lithospermate B, reduced hepatic CD36 expression in mice fed with High Fat Diet (HFD) ([@B131]; [@B128]; [@B113]). Dansameum reduced the expression level of CD36 in liver of apolipoprotein E-Knockout mice with NAFLD ([@B1]). In another mice model of NAFLD induced by high-fat and high-cholesterol diet, gypenosides which are a type of TCM extracted from plants downregulated CD36 level in the liver, alleviating the progression of hepatic steatosis ([@B39]). Berberine attenuated fat accumulation in the liver partially *via* suppressing the expression of FATP gene in HFD-fed mice ([@B155]).

Reducing Hepatic De Novo Lipogenesis {#s2_2}
------------------------------------

*De novo* lipogenesis in the liver is tightly controlled by metabolic hormones such as insulin, and glucose level ([@B127]). In the normal physiological status, high level of glucose promotes the secretion of insulin, activates carbohydrate-responsive element-binding protein (ChREBP), and meanwhile, provides substrate to facilitate lipogenesis in the liver ([@B127]). In terms of insulin, it activates sterol regulatory element-binding protein 1c (SREBP-1c) to up-regulate lipogenic enzymes, and then promotes *de novo* lipogenesis ([@B25]; [@B17]). [**Figure 2**](#f2){ref-type="fig"} shows the overview of lipogenesis in hepatocytes. Herbs and isolated natural compounds have been demonstrated by animal studies and *in vitro* studies to alleviate hepatic steatosis by ChREBP pathway and insulin-SREBP-1c pathway, as well as other factors, such as AMPK, PPARγ, SIRT1, inflammatory cytokines, immuno-modulation, and microRNAs. We summarized medicinal herbs and isolated natural compounds from recent literatures with the effects of reducing hepatic lipogenesis in [**Table 2**](#T2){ref-type="table"} and discussed some representative studies in detail as following.

![The overview of lipogenesis in hepatocytes.](fphar-11-00351-g002){#f2}

###### 

Medicinal herbs and isolated natural compounds with the effect of hepatic lipogenesis reduction.

  Herbs or compounds                                                                                                                                                                                                                                     Model                                                    Effect                                                                                                                                                    Mechanism                                                                                                                                                                                                                    References
  ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------
  Dansameum (*Salvia miltiorrhiza* root)                                                                                                                                                                                                                 Apolipoprotein E-Knockout mice                           Reduced hepatic lipogenesis and inflammation                                                                                                              Regulating LXR-*α*, PPAR-*γ*, SREBP-1, FAS, ACC1, and CD36                                                                                                                                                                   ([@B1])
  Alisol A                                                                                                                                                                                                                                               HFD-induced obese mice                                   Reduced hepatic steatosis and improved liver function                                                                                                     AMPK/ACC/SREBP-1c pathway                                                                                                                                                                                                    ([@B34])
  Ling-gui-zhu-gan decoction (*Poria cocos, Ramulus cinnamomi, Atractylodis macrocephalae Rhizoma* and *Radix glycyrrhizae* )                                                                                                                            HFD-fed rats                                             Reduced hepatic glycogen                                                                                                                                  Inhibited the activity of ACC, SREBP-1c and HMGCR, *via* inhibiting PPP1R3C targeting pathways                                                                                                                               ([@B23])
  Salvianolic acids                                                                                                                                                                                                                                      Ovariectomized rats                                      Reduced body weight gain and attenuated                                                                                                                   Blocking STAT-3/SREBP1 signaling                                                                                                                                                                                             ([@B23])
  Gyeongshingangjeehwan 18 (*Laminaria japonica*, *Rheum palmatum*, and *Ephedra sinica*)                                                                                                                                                                HFD-induced obese mice                                   Attenuated visceral obesity and NAFLD                                                                                                                     Down-regulated lipogenesis-related genes                                                                                                                                                                                     ([@B69])
  Cordycepin                                                                                                                                                                                                                                             Oleic acid-induced mouse FL83B hepatocytes               Attenuated lipid accumulation                                                                                                                             Activating AMPK and regulating mitochondrial function                                                                                                                                                                        ([@B122])
  Oxyresveratrol                                                                                                                                                                                                                                         HFD-fed mice                                             Ameliorated NAFLD                                                                                                                                         AMPK/SREBP-1c pathway                                                                                                                                                                                                        ([@B58])
  Berberine                                                                                                                                                                                                                                              MIHA and HepG2 cells                                     Reduced hepatosteatosis                                                                                                                                   Up-regulation of miR-373 decreased mRNA level target gene AKT1, leading to inhibition of AKT-mTOR-S6K signaling pathway in hepatocytes                                                                                       ([@B64])
  Genipin                                                                                                                                                                                                                                                HFD-fed mice                                             Reduced HFD-induced hyperlipidemia and hepatic lipid accumulation                                                                                         Increased the expression levels of miR-142a-5p, which bound to 3 untranslated region of SREBP-1c                                                                                                                             ([@B154])
  Gangjihwan (*Ephedra intermedia* Schrenk & C.A.Mey., *Lithospermum erythrorhizon* Siebold & Zucc., and *Rheum palmatum* L.)                                                                                                                            HFD-induced obese mice                                   Inhibited fat accumulation                                                                                                                                Modulation of lipogenic transcription factors SREBP-1c, PPAR-γand ChREBP-*α*                                                                                                                                                 ([@B44])
  Gangjihwan (*Ephedra intermedia* Schrenk & C.A.Mey., *Lithospermum erythrorhizon* Siebold & Zucc., and *Rheum palmatum* L.)                                                                                                                            HFD-fed C57BL/6 J mice and HepG2 cells                   Anti-obesity and anti-nonalcoholic steatohepatosis                                                                                                        Increased mRNA levels of fatty acid oxidation genes and decreased mRNA levels of genes for lipogenesis                                                                                                                       ([@B107])
  Dangguiliuhuang Decoction (root of Rehmannia Glutinosa, *Angelica acutiloba* Siebold et Zucc., *Coptis chinensis* Franch., *Radix Rehmanniae Praeparata*, *Astragalus propinquus*, *Scutellaria baicalensis*, and *Phellodendron chinense* Schneid.)   ob/ob mice                                               Normalized glucose and insulin level, increased the expression of adiponectin, diminished fat accumulation and lipogenesis, and promoted glucose uptake   ↓T cells, ↑ Tregs differentiation, ↓DCs maturation, ↓ DCs-stimulated T cells proliferation and secretion of IL-12p70 cytokine, promoted the interaction of DCs with Tregs, changed PI3K/Akt signaling pathway and↑ PPAR-γ.   ([@B15])
  Glycycoumarin                                                                                                                                                                                                                                          MCD diet mice                                            Prevented hepatic steatosis                                                                                                                               Activation of AMPK signaling pathway                                                                                                                                                                                         ([@B149])
  Gambigyeongsinhwan (Curcuma longa, Alnus japonica, and Massa Medicata Fermentata)                                                                                                                                                                      Otsuka Long-Evans Tokushima fatty rats and HepG2 cells   Suppressed hepatic steatosis and obesity-related hepatic inflammation                                                                                     ↓mRNA levels of FAS, ACC1, ChREBP alpha, and SREBP-1c                                                                                                                                                                        ([@B142])
  Alisol B 23-acetate                                                                                                                                                                                                                                    MCD diet-fed mice                                        ↓ALT, AST, TG                                                                                                                                             FXR-dependent, ↓hepatic lipogenesis through decreasing hepatic levels of SREBP-1c, FAS, ACC1 and SCD1 and ↑lipid metabolism *via* inducing PPAR α, CPT1 α, ACADS and LPL                                                     ([@B85])
  Herbal Formula HT048 (*Crataegus pinnatifida* leaf and *Citrus unshiu* peel extracts)                                                                                                                                                                  HFD-fed obese rats                                       Decreased obesity and insulin resistance                                                                                                                  ↓Genes involved in lipogenesis                                                                                                                                                                                               ([@B57])
  Jatrorrhizine hydrochloride                                                                                                                                                                                                                            HFD-induced obesity mouse model                          Attenuated hyperlipidemia                                                                                                                                 ↓ SREBP-1c and FAS, and induced PPAR- and CPT1A                                                                                                                                                                              ([@B135])
  Puerarin                                                                                                                                                                                                                                               Oleic acid (OA)-treated HepG2 cells                      Ameliorated hepatic steatosis                                                                                                                             ↑PPAR-α and AMPK signaling pathways, ↓SREBP-1 and FAS expression                                                                                                                                                             ([@B47])
  Protopanaxatriol                                                                                                                                                                                                                                       HFD-induced obesity (DIO) mice                           Alleviated steatosis                                                                                                                                      Inhibition of PPAR-γ activity                                                                                                                                                                                                ([@B148])
  Magnolia officinalis Rehder & E.H.Wilson                                                                                                                                                                                                               HepG2 cells and mouse normal FL83B hepatocytes           Attenuated TG biosynthesis                                                                                                                                Inhibition of SREBP-1c *via* AMPK phosphorylation                                                                                                                                                                            ([@B110])
  Lycium barbarum polysaccharide                                                                                                                                                                                                                         HFD-fed mice                                             Attenuate liver steatosis                                                                                                                                 ↓SREBP-1c expression *via* AMPK activation                                                                                                                                                                                   ([@B60])
  Houttuynia cordata Thunb.                                                                                                                                                                                                                              HepG2                                                    Attenuates Lipid Accumulation                                                                                                                             AMPK signaling                                                                                                                                                                                                               ([@B46])
  Berberine metabolites                                                                                                                                                                                                                                  HepG2                                                    TG-lowering effects                                                                                                                                       ↓Lipogenesis gene expressions through activation of the AMPK signaling pathway                                                                                                                                               ([@B14])
  3-Caffeoyl, 4-dihydrocaffeoylquinic acid from *Salicornia herbacea Salicornia europaea* L.                                                                                                                                                             HepG2                                                    Attenuated high glucose-induced hepatic lipogenesis                                                                                                       Prevented lipid accumulation by blocking the expression of SREBP-1c and FAS through LKB1/SIRT1 and AMPK activation                                                                                                           ([@B100])
  Fructus Xanthii (*Xanthium strumarium*)                                                                                                                                                                                                                HFD-fed rats                                             Attenuated hepatic steatosis                                                                                                                              ↓The expression of lipogenic genes                                                                                                                                                                                           ([@B59])

↑ means increase and up-regulate and ↓ means decrease and down-regulate.

Magnolia officinalis Rehder & E.H.Wilson, *Houttuynia cordata* Thunb., 3-Caffeoyl, 4-dihydrocaffeoylquinic acid from *Salicornia europaea* L., puerarin and four kinds metabolites of berberine attenuated lipid accumulation in HepG2 cells *in vitro via* down-regulation of lipogenesis gene expressions through activation of the AMPK signaling pathway ([@B14]) ([@B100]; [@B46]). Gyeongshingangjeehwan 18 (an herbal drug composed of *Laminaria japonica*, *Rheum palmatum*, and *Ephedra sinica*), Herbal Formula HT048 (*Citrus unshiu* and *Crataegus pinnatifida*), Fructus Xanthii (*Xanthium sibiricum* Patr.), *Lycium barbarum* polysaccharide, Jatrorrhizine hydrochloride, oxyresveratrol, and alisol A isolated from *Rhizoma alismatis* (Oriental Waterplantain Tuber.) attenuated liver steatosis in HFD-fed animals *via* regulating lipogenic genes, predominantly relating with downregulation of SREBP-1c expression *via* AMPK activation ([@B59]; [@B60]; [@B57]; [@B135]; [@B58]; [@B69]; [@B34]). Gangjihwan, a polyherbal composition of *Ephedra intermedia* Schrenk & C.A.Mey., *Lithospermum erythrorhizon* Siebold & Zucc., and *Rheum palmatum* L., showed anti-obesity and anti-nonalcoholic steatohepatosis effects in HFD-fed mice. Lipogenic transcription factors, SREBP-1c, PPAR-γ, and ChREBP alpha were involved in the action mechanism ([@B44]); ([@B107]). Molecular targets of FAS, ACC1, ChREBP alpha, and SREBP-1c were also found to be involved in the underlying mechanism of anti-hepatic steatosis and anti-obesity-related hepatic inflammation effect of Gambigyeongsinhwan in Otsuka Long-Evans Tokushima fatty rats and HepG2 cells ([@B142]).

Glycycoumarin, a representative of coumarin compounds isolated from licorice, and Alisol B 23-acetate exert ability of reducing hepatic lipogenesis in methionine-choline-deficient (MCD) diet-fed mice ([@B85]; [@B151]). MCD diet is a classical dietary model of non-alcoholic steato-hepatitis. With the lack of methionine and choline and high sucrose (40%) and fat (10%), impaired hepatic mitochondrial β-oxidation and very low-density lipoprotein (VLDL) synthesis are observed in mice ([@B41]). Glycycoumarin activated AMPK signaling pathway to reduce lipogenesis. Alisol B 23-acetate, a natural triterpenoid derived from TCM *Rhizoma alismatis* (Oriental Waterplantain Tuber.), decreased hepatic lipogenesis *via* FXR-dependent pathway. It decreased hepatic levels of SREBP-1c, FAS, ACC1 and SCD1, and promoted lipid metabolism *via* inducing PPAR α, CPT1 α, ACADS, and LPL ([@B85]). In an apolipoprotein E-knockout mice model, Dansameum (*Salvia miltiorrhiza* root), a kind of Korean polyherbal medicine, reduced hepatic lipogenesis, and inflammation *via* regulating PPAR-γ, SREBP-1c, FAS, ACC1, and CD36 ([@B1]).

Dangguiliuhuang Decoction, a TCM formula composed of *radix rehmanniae* (root of Rehmannia Glutinosa), *angelica* (*Angelica acutiloba* Siebold et Zucc.), *Coptis chinensis* Franch., *Radix Rehmanniae Praeparata* (Rehmannia root), *Astragalus propinquus* (the root of *astragalus membranaceus*), Chinese skullcap (*Scutellaria baicalensis*) and *Phellodendron amurense* (*Phellodendron chinense* Schneid.), is used for the treatment of autoimmune diseases and diabetes ([@B15]; [@B16]). In a study of ob/ob mice model, it normalized glucose and insulin level, diminished fat accumulation and lipogenesis, increased the expression of adiponectin, and promoted glucose uptake ([@B15]). It showed modulation abilities on inflammation and immune response. Dangguiliuhuang Decoction (composition as listed above) promoted the shift of pro-inflammatory to anti-inflammatory cytokines. Furthermore, it decreased T cells proliferation while increased regulatory T cells (Tregs) differentiation, reduced dendritic cells (DCs) maturation and secretion of IL-12p70 cytokine, decreased DCs-stimulated T cells proliferation, and promoted, the interaction of DCs with Tregs. In adipocytes and hepatocytes as well as DCs and T cells, Dangguiliuhuang Decoction treatment altered PI3K/Akt signaling pathway and increased PPAR-γ expression, indicating the ameliorated glucose and lipid metabolism ([@B15]).

MicroRNA (miR), a small non-coding RNA molecule, has been recently demonstrated to play a role in mediating the anti-hepatic steatosis effects of natural compounds derived from herbs. Berberine reduced steatosis in MIHA and HepG2 cells by mechanism associating with up-regulation of miR-373, which decreased its mRNA level target gene AKT serine/threonine kinase 1 (AKT1), resulting in the suppression of AKT-mTOR-S6K signaling pathway in hepatocytes ([@B16]). Genipin reduced HFD-induced hyperlipidemia and hepatic lipid accumulation in mice *via* increasing the expression levels of miR-142a-5p, which bound to 3'-untranslated region of SREBP-1c, thus leading to the inhibition of lipogenesis ([@B154]).

Increasing Lipolysis {#s2_3}
--------------------

Lipolysis is the catabolic process of hydrolytic cleavage of ester bonds in TG, leading to the production of fatty acids and glycerol, which could be further utilized for β-oxidation and subsequent ATP generation ([@B55]). It predominantly occurs in adipose tissues, but also in the liver, with different physiological functions. Dietary fat is digested into the gut lymphatic system as chylomicrons, which arrives at the liver through the circulation and release NEFAs through lipolysis which mediated mainly by lipoprotein lipase (LPL) ([@B108]). Other lipolytic enzymes contributing to hepatic TG metabolism include adiponutrin/patatin-like phospholipase domain containing 3 (PNPLA3) ([@B52]), lysosomal acid lipase (LAL) ([@B104]), arylacetamide deacetylase ([@B78]), hepatic lipase (HL)([@B19]) and some members of the carboxylesterase family. In adipose tissue, inhibition of lipolysis improves glucose metabolism and insulin sensitivity, whereas in liver tissue, increasing lipolysis facilitates the attenuation of hepatic steatosis.

As far from now, limited herbs were found to show regulatory effect on hepatic lipolysis. *Lavatera critica* (Cornish mallow), a green leafy vegetable, attenuated hepatic lipid accumulation induced by HFD *via* reversing lipolysis genes acetyl-CoA carboxylase ([@B123]). *Nitraria retusa* (Forssk.) Asch. ethanolic extract modulated the lipolysis-lipogenesis balance in the liver of db/db mice ([@B123]). Caffeic acid upregulated the phosphorylation of AMPK and its primary downstream targeting enzyme, acetyl-CoA carboxylase, to promote the lipolysis in HepG2 cells with oleic acid administration ([@B68]). *Polygonatum stenophyllum* (PS) Maxim. rhizome showed efficacy on menopausal obesity by activating lipolysis-related genes including hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL) ([@B56]). Mulberry (Fructus Mori) water extracts promoted hepatic lipolysis and protected liver from steatosis in obesity ([@B95]). More herbs or natural compounds exerted effects on lipolysis in adipose tissues and attenuated hepatic steatosis *via* liver-adipose tissue crosstalk, which are not going to be discussed in detail here.

Induction of Lipophagy {#s2_4}
----------------------

In addition to lipolysis, lipid breakdown can also be accessed *via* lipophagy, a special kind of autophagy to degrade lipid droplets ([@B117]; [@B51]). It is a process that the double membrane wraps lipid droplets and sends them to lysosomes to form autolysosomes for degradation of excessive lipid droplets deposited in cells ([@B70]; [@B130]). It plays a vital role in maintaining the cellular steady state. During the early stage of NAFLD, lipophagy is activated in response to acute increase in lipid availability, thus reduce lipid deposition ([@B22]; [@B42]). However, in the condition of such as long-lasting high fat dieting, hepatic lipophagy is impaired when lipids are sustained overwhelmed ([@B53]; [@B22]; [@B42]). Growing evidence raised from recent studies indicate that lipophagy is partially suppressed in patients and animal models of NAFLD and restoring lipophagy may slow the progression of hepatic steatosis. Lipophagy could be activated by various approaches, such as mTOR and AMPK-targeting agents. Glycycoumarin, a representative of coumarin compounds isolated from licorice, mitigated hepatic steatosis partially through AMPK-mediated lipophagy in a murine model of NAFLD induced by MCD diet ([@B149]). Dioscin is a saponin extracted and isolated from *Polygonatum zanlanscianense* Pamp. It has been proposed as a healthcare product against hepatic fibrosis with remarkable ability to inhibit the expression of p-mTOR/mTOR level and sequentially promote autophagy ([@B133]). In another study, Bergamot polyphenol fraction prevents NAFLD *via* stimulation of lipophagy in cafeteria dietinduced rat model of metabolic syndrome. The increased levels of LC3 and Beclin 1, and concomitant reduction of SQSTM1/p62 proved the promoted lipophagy with the treatment of Bergamot polyphenol fraction ([@B90]). Increasing number of herbs or natural products have been demonstrated to exert significant effects on regulating lipophagy in the liver. Current understanding of mechanisms associated with autophagy/lipophagy of herbal medicines and natural products in preventing and treating NAFLD has been well reviewed in [@B150], which could be referred for further reading.

In alcoholic liver diseases (ALD), upon acute consumption of alcohol, lipophagy is activated in hepatocytes, serving as a defensive mechanism against injury to steatosis ([@B134]). However, it is impaired by chronic alcohol exposure, which is likely due to the activation of mTOR signaling and decreased lysosomal biogenesis in hepatocytes ([@B51]; [@B138]). There are growing number of herbs and natural products have been found to protect liver from injury induced by alcohol by mechanism of lipophagy stimulation. Corosolic acid, a compound derived from the leaves of *Langertroemia speciosa* L Pers., protected the liver from alcoholic-induced liver injury partially *via* restoring hepatic lipophagy due to mTORC1 suppression after AMPK activation ([@B30]). Another natural compound, quercitin, which is extensively found in many fruits and herbal plants, remarkably reversed the alcohol-induced blockade of TFEB nuclear localization, *via* restoring lysosome function and autophagic flux in livers of ethanol-fed C57BL6 mice ([@B66]). Salvianolic acid A, a phenolic carboxylic acid extracted from *Salvia miltiorrhiza Bunge*, reduced hepatic steatosis induced by alcohol administration in rats. The action mechanism is attributed to enhanced autophagosome-lysosome fusion after restoring lysosomal cathepsin activities ([@B116]).

As a matter of fact, the field of lipophagy in liver diseases has yet to be fully developed. Its pathological role in different stages and circumstances of various liver disorders still needs to be revealed. Nevertheless, current studies concerning lipophagy have already provided new insights on lipid metabolism and energy homeostasis in the liver. It represents a promising path forward to the therapeutic of hepatic steatosis. Pharmaceutic agents including herbs, natural products or compounds targeting lipophagy in the liver deserve to be further investigated in future basic and clinic researches.

Enhancing Fatty Acid β-Oxidation {#s2_5}
--------------------------------

Fatty acid could be oxidized by β-oxidation, α-oxidation, omega-oxidation, and peroxisomal oxidation, among which β-oxidation is the major type occurring in the mitochondria matrix ([@B125]). In β-oxidation, two carbon subunits from fatty acids are removed repeatedly until the fatty acid carbon chain is fully degraded to form acetyl-CoA, which is further oxidized to carbon dioxide and H~2~O in the tricarboxylic acid cycle (TCA) ([@B12]). β-oxidation plays a vital role in hepatic lipid consumption. A variety of proteins and enzymes are involved in the process of mitochondrial fatty acid β-oxidation, such as plasma membrane fatty acid binding protein (FABPpm) ([@B29]), fatty acid transport protein (FATP) ([@B89]), carnitine acylcarnitine translocase (CACT) ([@B99]), carnitine palmitoyltransferases 1 and 2 (CPT1/2), etc. ([@B10]; [@B36]). More importantly, mitochondrial fatty acid β-oxidation is regulated by both transcriptional and posttranscriptional mechanisms. Peroxisome proliferator-activated receptors (PPARs) are activated by fatty acids, having specific roles in physiology of different tissues ([@B144]; [@B54]). In liver, PPARα controls many genes involved in mitochondrial fatty acid β-oxidation ([@B54]). In terms of posttranscriptional mechanism, the inhibition of CPT1 by malonyl-CoA is a vital regulatory step. The levels of malonyl-CoA in hepatocytes are regulated *via* degradation induced by malonyl-CoA decarboxylase and *via* production by acetyl-CoA carboxylase (ACC)([@B91]). PPARs-mediated activation persuades transcription of malonyl-CoA decarboxylase, and phosphorylated AMPK inactivated ACC ([@B109]). They stimulate mitochondrial fatty acid β-oxidation by reducing malonyl-CoA levels. Additionally, peroxisome proliferator activated receptor gamma coactivator 1-alpha (PGC-1α) has also been regarded as a factor of posttranscriptional regulation of β-oxidation ([@B28]). The activation of PGC-1α is mediated by AMPK *via* SIRT1-mediated deacetylation ([@B13]).

Many herbs and active compounds protect liver from steatosis *via* regulation of fatty acid β-oxidation. Herbacetin is a dietary flavonoid with plenty of pharmacological activities. Its anti-hyperglycemic and anti-hyperlipidemic properties was associated with up-regulation of CPT to enhanced β-oxidation and hepatic lipid metabolism ([@B124]). Acteoside, a major compound isolated from leaves of *Aloysia citriodora* Palau (syn. *Lippia triphylla*), promoted lipolysis and fatty acid oxidation by enhancing mRNA expression level of adipose triglyceride lipase (ATGL) and CPT-1, and thus improved hepatic lipid metabolism ([@B152]). Cordycepin enhanced β-oxidation and suppressed lipid accumulation *via* regulating AMPK pathway and mitochondrial fusion in hepatocytes ([@B122]).

In China, the modified Longdan Xiegan Tang (mLXT, composed of Scutellaria baicalnsis Geprgi, Gardenia jasminoides, Adenophora capillaris, Akebia quinate, Plantago asiatica, Angelica sinensis, Rehmannia glutinosa, Alisma plantago-aquatica, Bupleurum gibraltaicum, and Glycyrrhiza uralensis) has been used clinically for various liver diseases such as NAFLD. It was found to activate hepatic expression of PPAR α and its target genes associated with fatty acid β-oxidation ([@B106]). Babaodan, a TCM, up-regulated the expression of CPT-1 and PPAR α in liver of HFD-fed mice with NAFLD, leading to the enhanced β-oxidation ([@B113]). Rosa rugosa Thunb., another TCM, is used for treatment of cardiovascular diseases and diabetes, hypertension, hyperlipidemia, and inflammation. R. rugosa flavonoids, the major components in R. rugosa Thunb., were observed to up-regulate the mRNA expression of PPAR α and its downstream gene of acyl-coenzyme A oxidas X (ACOX) in a mouse model of hypertriglyceridemia ([@B8]). Thereby, R. rugosa flavonoids could reduce TG in hepatocytes via rising β-oxidation. *Gynura procumbens* Merr., one of precious medicinal herbs of Asterceaes, up-regulated the mRNA expression of genes involved in β-oxidation, including PPAR α, CPT1 α, ACOX, fatty acid-binding proteins 5 (FABP5), stearoyl-coenzyme A desaturase-1 (SCD-1), glycerol-3-phosphate acyltransferase (mGPAT), microsomal triglyceride transfer protein (MTTP), to increase β-oxidation and efflux of fatty acids in liver of mice fed with MCD diet, and consequently decreased hepatic lipid accumulation ([@B77]). An herbal formula Gyeongshingangjeehwan 18 (GGEx18), composed of Laminaria japonica Aresch (Laminariaceae), Rheum palmatum L. (Polygonaceae) and Ephedra sinica Stapf (Ephedraceae), has traditionally been described to against obesity and related metabolic disease such as dyslipidemia. In HFD-fed mice receiving GGEx18, genes related to hepatic fatty acid β-oxidation was higher compared to mice fed with only HFD ([@B69]).

Evidence from recent studies has also indicated that some natural compounds promoted fatty acid oxidation by regulating the AMPK/PGC-1α signaling pathway. Yellow pigments, monascin, and ankaflavin, as secondary metabolites derived from monascus-fermented products, could reduce fatty acid accumulation partly mediated by the AMPK signaling activation and enhancement of β-oxidation by PGC-1α ([@B37]). Myricetin, a natural flavonol with many biological activities, decreased PGC-1α acetylation through SIRT1 activation, and thus enhanced mitochondrial activity, suggesting its potential role in regulating hepatic lipid metabolism ([@B45]).

Clinical Trials {#s3}
===============

Given to the encouraging effects of herbal medicines on liver diseases, plenty of clinical trials have been extensively performed. The potential therapeutic benefits of herbal medicines in patients with NAFLD have been reviewed in several papers in recent years ([@B132]; [@B9]; [@B98]). In present review, we focused on the efficacy of herbal medicines to mediate lipid metabolism and attenuate hepatic steatosis.

Dava Al-Balgham, as one of the traditional medicine products composed of *Nigella sativa* L., *Pistacia lentiscus* L., *Zataria multiflora* Boiss. (ZM), and *Trachyspermum ammi*, was tested for its effect on NAFLD by a randomized, double-blinded, placebo-controlled trial with 76 NAFLD patients. Placebo or Dava Al-Balgham were consumed with each meal for three months. The results showed that Dava Al-Balgham could cause weight loss and have anti-hypolipidemic effect ([@B35]).

The effect of *Z. multiflora* supplementation on NAFLD was studied by a randomized double-blind placebo-controlled clinical trial. Total 85 patients with NAFLD were treated with ZM powder (700 mg) or placebo twice daily for 3 months. However, no significant difference between two ZM-treated groups and placebo groups regarding ALT, TNF-α, grade of fatty liver in ultrasonography, lipid profiles, and high sensitive C-reactive protein (hs-CRP), while it could improve insulin resistance in patients with NAFLD. Further studies with larger sample size and longer duration are recommended ([@B145]).

A 12-weeks randomized, controlled, double-blind trial included with was 44 NAFLD patients, was performed to evaluate the efficacy of *Capparis spinosa* L. on disease regression of NAFLD. Patients are randomly divided into control (n=22) or caper (n=22) group. The caper group was treated with 40-50 g caper fruit pickles with meals every day. Results obtained after treatment of 12 weeks indicated that the grade of fatty liver and serum lipoproteins were improved by *C. spinosa* administration ([@B50]).

We further checked the registered clinical trials about testing effects of the herbs and natural products on fatty liver *via* the website of [www.clinialtrial.gov](www.clinialtrial.gov). The intensively studied herbs and derived compounds are resveratrol, ginseng, and ginger, which were discussed in detail in following. Other herbs and some natural products that are undergoing or were performed clinical trials on fatty liver diseases are listed in [**Table 3**](#T3){ref-type="table"}.

###### 

Registered clinical trials of herbs and natural products on fatty liver diseases (Referred to <http://www.ClinicalTrials.gov> website).

  NCT number    Status                    Conditions                                                               Interventions                                                                                                                                                        Outcome Measures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Population                                                                Dates
  ------------- ------------------------- ------------------------------------------------------------------------ -------------------------------------------------------------------------------------------------------------------------------------------------------------------- --------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------- ------------------------------------------------------------------
  NCT02030977   Completed                 NAFLD                                                                    Resveratrol                                                                                                                                                          ALT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Enrollment: 50 Age: 18 Years to 80 Years (Adult, Older Adult) Sex: All    Study Start: June 2012 Study Completion: March 2013
  NCT01464801   Completed                 Fatty liver                                                              Resveratrol                                                                                                                                                          Change in hepatic steatosis and inflammationAssessment of tolerability and side-effects                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Enrollment: 28 Age: 18 Years to 70 Years (Adult, Older Adult) Sex: All    Study Start: September 2011 Study Completion: June 2015
  NCT01446276   Completed                 Obesity NAFLD                                                            Resveratrol                                                                                                                                                          Hepatic VLDL-TG secretion and peripheral VLDL-TG clearanceBasal and insulin stimulated free fatty acid (FFA) and glucose turnoverVLDL-TG oxidationBody composition (fat mass, fat-free mass, percent fat, visceral fat mass)lipoprotein lipase activity and fat cell size in abdominal and femoral adipose tissue biopsyBaseline data                                                                                                                                                                                                                                                                                                                     Enrollment: 26 Age: 25 Years to 65 Years (Adult, Older Adult) Sex: Male   Study Start: November 2011 Study Completion: April 2014
  NCT04130321   Not yet recruiting        OverweightMicrotiaEndotoxemiaMetabolic SyndromeInsulin ResistanceNAFLD   Camu camu (Myrciaria dubia)                                                                                                                                          Change in Gut Microbiota Composition and DiversityChange in fat accumulation in the liverChange in EndotoxemiaChange in Intestinal permeabilityChange in Inflammation state of the tissueChange in Short chain and branched chain fatty acids in the fecesChange in gut healthChange in stool consistencyChange in Glucose homeostasisChange in Lipid profile and 8 more                                                                                                                                                                                                                                                                                  Enrollment: 32 Age: 18 Years to 75 Years (Adult, Older Adult) Sex: All    Study Start: January 6, 2020 Study Completion: June 30, 2022
  NCT0394512    Completed                 Liver Dysfunction                                                        Red ginseng                                                                                                                                                          Liver enzyme                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              Enrollment: 94 Age: 37 Years to 63 Years (Adult) Sex: All                 Study Start: January 1, 2018 Study Completion: December 31, 2018
  NCT03260543   Completed                 NAFLD                                                                    Fermented ginseng powder                                                                                                                                             Changes of ALT Changes of Liver function indexChanges of fatty liver gradeChanges of lipid metabolism indexChanges of total antioxidant capacityChanges of imflammation indexChanges of Multidimensional Fatigue Scale                                                                                                                                                                                                                                                                                                                                                                                                                                    Enrollment: 90 Age: 19 Years to 70 Years (Adult, Older Adult) Sex: All    Study Start: July 2016 Study Completion: August 2017
  NCT04049396   Completed                 NAFLD                                                                    Berberine                                                                                                                                                            ALT; AST; ALP; fasting blood sugar; total cholesterol; LDL-Cholesterol; HDL - Cholesterol; TG                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Enrollment: 50 Age: 18 Years to 65 Years (Adult, Older Adult) Sex: All    Study Start: October 1, 2018 Study Completion: June 15, 2019
  NCT02535195   Completed                 NAFLD                                                                    Ginger                                                                                                                                                               Serum levels of the ALT liver enzymeSerum levels of the AST liver enzymecontrolled attenuation parameter(CAP) score                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Enrollment: 60 Age: 18 Years to 70 Years (Adult, Older Adult) Sex: All    Study Start: March 2013 Study Completion: August 2015
  NCT02289235   Enrolling by invitation   Fatty LiverDiabetes Mellitus, Type 2                                     Ginger                                                                                                                                                               Change in ALT levelChange in AST levelChange in score of fatty liver in fibroscanChange in Gama GT (\#- glutamyl transpeptidase) levelsNumber of patients with adverse events                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Enrollment: 90 Age: 20 Years to 65 Years (Adult, Older Adult) Sex: All    Study Start: November 1, 2018 Study Completion: December 1, 2019
  NCT03864783   Recruiting                NAFLDInsulin ResistanceGlucose Tolerance ImpairedObesity, Abdominal      Curcumin (Meriva^®^)                                                                                                                                                 Curcumin's effect on steatosisTotal amino acids in plasmaTotal amino acids in plasmaCurcumin's effect on plasma concentration of ureaCurcumin's effect on urin concentration of ureaCurcumin's effect on serum concentration of inflammatory marker interleukin (IL)-1bCurcumin's effect on serum concentration of inflammatory marker IL-2Curcumin's effect on serum concentration of inflammatory marker IL-6Curcumin's effect on serum concentration of inflammatory marker IL-10Curcumin's effect on serumconcentration of inflammatory marker tumor necrosis factor (TNF)- alphaCurcumin's effect on plasma concentration of adipokinesand 34 more   Enrollment: 40 Age: 20 Years and older (Adult, Older Adult) Sex: Male     Study Start: March 5, 2019 Study Completion: October 2020
  NCT03073343   Recruiting                Non-Alcoholic Fatty Liver Disease Non Insulin Dependent DiabetesALT      Betaine                                                                                                                                                              ALT                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Enrollment: 48 Age: 18 Years to 75 Years (Adult, Older Adult) Sex: All    Study Start: November 12, 2013 Study Completion: June 30, 2020
  NCT02973295   Recruiting                NAFLD                                                                    Silymarin                                                                                                                                                            Change (Reduction)of parameters of liver steatosis defined by CAP (Controlled Attenuation Parameter) and liver fibrosis defined byLSM (liver stiffness measurements) during the 6 months periodChange in liver enzymes in period of 6 monthsChange in insulin resistance in period of 6 monthsChange in lipidogram in period of 6 months                                                                                                                                                                                                                                                                                                                  Enrollment: 400 Age: 18 Years to 70 Years (Adult, Older Adult) Sex: All   Study Start: September 20, 2019 Study Completion: June 30, 2021
  NCT02929901   Completed                 Type 2 Diabetes Nonalcoholic Fatty Liver                                 Caffeine and chlorogenic acid                                                                                                                                        Hepatic steatosisGlucoseGlycated hemoglobin (HBA1C)ALTASThs- CRP)gut microbiota                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Enrollment: 200 Age: 30 Years to 65 Years (Adult, Older Adult) Sex: All   Study Start: December 2016 Study Completion: March 2019
  NCT02908152   Unknown status            Type 2 DiabetesNonalcoholic Fatty Liver                                  Curcumin                                                                                                                                                             Hepatic steatosisGlucoseHBA1CALTAST                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       Enrollment: 50 Age: 30 Years to 65 Years (Adult, Older Adult) Sex: All    Study Start: February 2017 Study Completion: October 2017
  NCT02006498   Completed                 NAFLD                                                                    Sillymarin                                                                                                                                                           To assess the efficacyof Silymarin as defined by an improvement in non-alcoholic steatosis (NAS) activity score by at least 30% from baseline compared to placeboTo assess the safety and adverse event profile of Silymarin compared to placebo                                                                                                                                                                                                                                                                                                                                                                                                          Enrollment: 99 Age: 18 Years and older (Adult, Older Adult) Sex: All      Study Start: June 2012 Study Completion: December 2015
  NCT01940263   Completed                 NAFLD                                                                    Anthocyanin                                                                                                                                                          Biomarkers related to oxidative stressBiomarkers related to inflammation                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  Enrollment: 63 Age: 18 Years to 65 Years (Adult, Older Adult) Sex: All    Study Start: June 2013 Study Completion: June 2014
  NCT02307344   Unknown status            Nonalcoholic SteatohepatitisLiver Steatosis                              Nigella sativa L.                                                                                                                                                    Effect of Nigella Sativa on Liver Triglyceride ConcentrationEffect of Nigella Sativa on Improvement in NASH Activity IndexEffect of Nigella Sativa on Fibrosis Staging                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Enrollment: 100 Age: 18 Years and older (Adult, Older Adult) Sex: All     Study Start: January 2015 Study Completion: January 2017
  NCT02303314   Completed                 NAFLD                                                                    Trigonella Foenum-graecum Seed Extract                                                                                                                               Liver stiffness change                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    Enrollment: 35 Age: 18 Years to 70 Years (Adult, Older Adult) Sex: All    Study Start: November 2014 Study Completion: September 2017
  NCT01707914   Completed                 NAFLD                                                                    Chinese bayberry juice (Myrica rubra)                                                                                                                                Plasma lipids profile                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     Enrollment: 44 Age: 18 Years to 25 Years (Adult) Sex: All                 Study Start: June 2012
  NCT01677325   Completed                 NAFLD                                                                    Drug: Chinese herb (YiQiSanJu) (Angelica sinensis, Rehmannia, Cinnamomum cassia, Glycyrrhiza uralensis, Eucommia ulmoides, Achyranthes bidentate, Lycium chinense)   The CT ratio of liver/spleenBMI(Body Mass Index)liver functionlipid profileNEFAHOMA indexadiponectinIL-6hs-CRP (C-reactive protein)TNF-aleptin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            Enrollment: 40 Age: 18 Years to 65 Years (Adult, Older Adult) Sex: Male   Study Start: January 2007 Study Completion: January 2008
  NCT01210989   Completed                 NAFLD                                                                    Phyllanthus urinaria L.                                                                                                                                              Histologic NAFLD activity scoreALT normalizationMetabolic endpointsChanges in magnetic resonance spectroscopyLiver stiffness measurementBiomarkers of NASH and liver fibrosis                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Enrollment: 60 Age: 18 Years to 70 Years (Adult, Older Adult) Sex: All    Study Start: May 2010 Study Completion: May 2012
  NCT00816465   Completed                 NAFLD                                                                    Hoodia gordonii (Masson) Sweet ex Decne.                                                                                                                             Decreased insulin resistanceSafetyReduced hepatic injuryReduced weight/BMI/abdominal circumference                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Enrollment: 20 Age: 18 Years to 65 Years (Adult, Older Adult) Sex: All    Study Start: May 2009 Study Completion: August 2010

Resveratrol is a stilbenoid and a phytoalexin generated by several plants, such as red grapes in response to stimuli ([@B32]). It is an activator of AMPK and SIRT1, and thus has a critical role in promoting fat breakdown and removal from the liver, preventing liver damage and inhibiting the progression of NAFLD ([@B111]; [@B18]; [@B121]). Resveratrol has been involved in three trials (NCT01446276; NCT01464801; NCT02030977) included patients of fatty liver, NAFLD, and obesity.

Another herb, ginseng, has been traditionally used for more than 2,000 years with various biological effects. A great deal of preclinical studies have demonstrated the protective effects of ginseng on liver diseases, including ALD and NAFLD. Korean Red Ginseng (Panax ginseng) ([@B94]) enhanced the decreased phosphorylation of AMPK induced by ethanol consumption. Notably, it reduced the accumulation of fat in hepatocytes caused by ethanol *via* regulation of SREBP-1, SIRT-1 and PPAR-α ([@B40]; [@B94]). Clinical trial (NCT0394512) has been performed to study the effect of red ginseng on liver dysfunction. Fermented ginseng powder has also been tested to study its efficacy on NAFLD (NCT03260543).

Ginger is the root of *Zingiber officinale* Roscoe and is one of the most used spices in many countries ([@B40]). It contains active compounds, such as shogaol, gingerol, zingerone, and β-bisabolene. It has been shown that ginger can reduce insulin resistance and serum TG level in patients with Type II diabetes and hyperlipidemia ([@B5]). In a randomized, double-blind, placebo-controlled clinical trial with 44 patients of NAFLD, ginger supplementation significantly reduced the levels of ALT, inflammatory cytokines, γ-glutamyl transferase, as well as hepatic steatosis grade and the insulin resistance index in comparison to the control group. Another clinical trial of ginger supplement on fatty liver or Type 2 Diabetes Mellitus is still undergoing (NCT02289235).

Meta-Analysis Studies {#s4}
=====================

HuoXueHuaYu (HXHY), a TCM formula, has been widely used in clinic for patients with NAFLD. Cai et al. performed a meta-analysis of randomized controlled trial of HXHY in NAFLD. There are 13 studies involving 1429 patients which 654 patients receiving conventional treatment group and 775 patients belonged to HXHY group. HXHY showed better ability on lowing TC and TG levels than that of conversational treatment. HXHY might be an effective and safe therapy for NAFLD, and trials with rigorous design, multicenter, large-scale, and high-quality worldwide are still expected ([@B11]).

Erchen Decoction (ECD), a TCM formula, is often used in the therapy of various diseases. A meta-analysis of the efficacy of ECD for the treatment of NAFLD by PRISMA systematic review standard has been performed. Seven randomized controlled trial with a total of 1951 participants were included in this study. The analysis results showed that patients with ECD treatment showed an improved status compared to the conventional treatment. Longer follow-up periods and larger-scale randomized controlled trial are still required to evaluate the efficacy of ECD in NAFLD ([@B63]).

The efficiency and safety of a famous TCM Danshen in the treatment of NAFLD has also been analyzed by a meta-analysis study. Eight randomized controlled trials with 800 patients of NAFLD were identified. The results indicated that Danshen had improved total effectiveness rate, lower level of TC, TG, LDL, ALT, and AST, suggesting that Danshen may have potential effects on NAFLD, while multicenter large-sample randomized clinical trials are still expected to confirm the efficacy and safety of Danshen ([@B96]).

Another study performed by Narjes et al. on 2017 has evaluated the efficiency of all kinds of TCM on the treatment of NAFLD. Literature were searched on China National Knowledge and PubMed from 1995 to 2010. Total 5904 patients from 62 randomized controlled trials were included for meta-analysis. Results showed that TCM had a better effect on the normalization of ALT level and disappearance of radiological steatosis for the patients of NAFLD. Finally, authors concluded that TCM is of modest benefit to the therapy of NAFLD ([@B114]).

Conclusions and Perspectives {#s5}
============================

Due to the positive efficacy and minimal side effects, herbal medicines have obtained increasing attention as alternative therapeutic agents for liver disorders and dyslipidemia. Increasing evidence from laboratory studies suggests that many herbs, natural products, and derived compounds could inhibit the progression of hepatic steatosis. A variety of mechanisms have been demonstrated to be implicated in preventing hepatic steatosis and modulating lipid metabolism by herbs, including reducing hepatocyte fatty acid uptake and trafficking, reducing hepatic *de novo* lipogenesis, increasing lipolysis, inducing lipophagy, enhancing fatty acid β-oxidation. In particular, SREBP-1c, PPARα, AMPK, and SIRT1 signaling pathways have been highlighted as crucial molecular targets of action mechanisms by which herbal medicines regulate hepatic lipid metabolism. Current clinical evidences and meta-analysis showing the positive impacts of herbal medicines on the hepatic lipid metabolism pathways are still not strong enough. Further multicenter large-sample randomized clinical trials are still required to confirm the efficacy and safety of herbal medicines on hepatic lipid metabolism. Herbs mix and single medical plants as well as their components have been widely applied in the treatment of NAFLD. We consider the main actor should be the active components. For both herbs mix and single medical plants, they are containing many compounds, which may act synergistically in ways to enhance the therapeutic effects. Identifying the active components in herbs is a crucial and significant subject for the development of TCM. Currently, network pharmacology-based strategy has been extensively used for the prediction of the active components from herbs. Network pharmacology is an approach based on systems biology, poly-pharmacology, and molecular networks, to analyze relationships between drugs and diseases in recent decade, which has attracted considerable attention among Chinese medicine researchers for its ability in predicting and illustrating interactive relationships between numerous components and targets of herbal medicines. Network-based pharmacological analysis is a desirable approach as well as a good tool of in silico prediction for investigating the mechanisms of action for herbs and formulae and their potential bioactive components at molecular and systematic levels, which renders more effective subsequent exploration with experimental approaches. With the promising and effective prediction, subsequently validation experiments in laboratory and bench would be performed to confirm their pivotal role. In conclusion, herbal medicines have the potency to be alternative and complementary medical therapies to current pharmaceuticals for the treatment of liver diseases with lipid metabolism disorder.
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